uMotif
Key Facts
Platform deployed to 12 of the top 20 global pharma, capturing data in more than 25 therapy areas across clinical phase trials and real-world studies. Multi award winning platform, peer review published in Nature and other publications. Largest study captured over 5.1 million data points from 13,000 participants, many of whom tracked every day for more than 6 months Scalable cloud-based platform can be quickly configured for each new project
Successes in UK/NHS
Deployed in NHS studies in multiple conditions: Parkinson’s: NHS hospital study demonstrated enhanced patient experience and medications adherence, published in Nature Parkinson’s: https://www.nature.com/articles/s41531-016-0003-z. Funded through Small Business Research Initiative, partnering with Parkinson’s UK and 7 of the UK’s top neurologists Colorectal cancer: deployment at Christie Hospital in Manchester with Mark Saunders, Consultant Clinical Oncologist, with funding from NHS Vanguard programme Diabetes: working with Dr Pratik Choudhary, Project Lead and Senior Lecturer and Consultant in Diabetes at King's College London to support virtual trial element of pan-European Hypo-RESOLVE study. Large study funded by Innovative Medicines Initiative involving deployment at 8 sites in 5 European countries Rheumatology: large-scale real-world study with Professor Will Dixon from Manchester University engaged 13,000 people to track their pain and the weather every day for 6 months. The ‘Cloudy with a Chance of Pain’ study has been published in Nature (https://www.nature.com/articles/s41746-019-0180-3) and featured globally in the press (https://www.washingtonpost.com/weather/2020/05/28/weather-aches-pains-research/) as the leading example of highly engaging research, helping unlock new insights
Company details
Website
www.umotif.com/ ↗Markets already exporting to
Europe – main 5, Nordics, Eastern Europe USA Canada Australia
Desired Markets
Europe (All) North America APAC
Desired customer types
Major pharmaceutical companies Mid-tier pharmaceutical companies Biotech companies Medical device companies CROs (Contract Research Organisations)